Tissue Collection for Understanding Intervertebral Disc Degeneration and Back Pain
NCT ID: NCT01633034
Last Updated: 2024-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
200 participants
OBSERVATIONAL
2011-01-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Biomarkers and Molecular Targets Involved on Intervertebral Disc Degeneration and Discogenic Pain
NCT06349226
MR Elastography for the Herniated Intervertebral Disc
NCT03340545
Molecular Characterization of Spinal Tissue
NCT03492372
The Five-repetition Sit-to-stand Test for Lower Back Pain or Radiculopathy
NCT03303300
Advanced MR Imaging in Patients With Painful, Degenerative Disc Disease: A Pilot Study
NCT00706459
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients requiring surgery in lumbar spine region (L1-L2 to L5-S1)
3. Potential procedures: Spinal stenosis, discectomy, laminectomy, lumbar fusion, disc herniation.
Exclusion Criteria
2. Patients who have had a discography procedure performed at the same disc level as the one being operated on.
3. Known inflammatory conditions- Rheumatoid arthritis, Osteomyelitis, Discitis, Gout, Ankylosing spondylitis, and other infections.
4. Oncologic conditions- any history of cancer of any type.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwell Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mitchell Levine, MD
Role: PRINCIPAL_INVESTIGATOR
Northwell Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
North Shore University Hospital
Manhasset, New York, United States
Lenox Hill Hospital
Manhattan, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-329A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.